Beijing Foyou Pharma CO.,LTD (SHA:601089)

SHA:601089 Revenue

Beijing Foyou Pharma CO.,LTD had revenue of 912.95M CNY in the quarter ending September 30, 2026, with 2.97% growth. This brings the company's total for the last twelve months to 3.61B, up 5.49% year-over-year. In the year 2025, Beijing Foyou Pharma CO.,LTD had annual revenue of 3.50B with 1.71% growth. That makes Beijing Foyou Pharma CO.,LTD the 10,838th largest company in the world by revenue and 1,803rd in China.

• Revenue (ttm): 3.61B
• Revenue Growth: +5.49%
• P/S Ratio: 1.95
• Revenue / Employee: 922.96K
• Employees: 3,908
• Market Cap: 7.03B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicine 3.31B 94.2%
• Medical Instruments 201.97M 5.8%

By Geography

Chart

• East China 1.38B 40.0%
• North China 532.67M 15.5%
• Southwest 452.01M 13.1%
• Central China 367.80M 10.7%
• South China 328.40M 9.5%
• Northeast 212.65M 6.2%
• Northwest 124.72M 3.6%
• Other 48.16M 1.4%

Fiscal year ended Dec 31, 2025 See the full SHA:601089 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.50B	58.80M	1.71%
Dec 31, 2024	3.45B	106.01M	3.17%
Dec 31, 2023	3.34B	99.48M	3.07%
Dec 31, 2022	3.24B	402.44M	14.18%
Dec 31, 2021	2.84B	302.37M	11.93%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error